Home › Funds › Fortress Investment Group LLC › RNA
Fortress Investment Group LLC position in RNA
ATRIUM THERAPEUTICS INC · Health Care
Fortress Investment Group LLC reported holding 20,000 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$166K, representing 0.03% of its reported portfolio and ranking #24 among its reported holdings. Fortress Investment Group LLC has disclosed RNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Fortress Investment Group LLC's RNA position evolved
Fortress Investment Group LLC first disclosed a stake in RNA in Q1 2026 at 22,033 shares (US$295K). Across 2 filings, Fortress Investment Group LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 20,000 shares valued at US$166K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 22.03K | $294.58K | New |
| Q3 2026 | 20.00K | $165.60K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RNA and 13F data
RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 88 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), O'Connor Alternative Investments LLC (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RNA
- Sessa Capital IM, L.P. 1.50M sh · $20.18M · Q2 2026
- TIG Advisors, LLC 561.53K sh · $7.55M · Q2 2026
- O'Connor Alternative Investments LLC 559.14K sh · $4.63M · Q3 2026
- Bracebridge Capital, LLC 524.48K sh · $4.34M · Q3 2026
- Arbiter Partners Capital Management LLC 311.72K sh · $2.58M · Q3 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K sh · $2.02M · Q2 2026
- Kalehua Capital Management LLC 112.65K sh · $932.76K · Q3 2026
- Athos Capital Ltd 107.97K sh · $894.00K · Q3 2026
- Marble Bar Asset Management LLP 103.90K sh · $860.27K · Q3 2026
- Trium Capital LLP 58.38K sh · $483.40K · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K sh · $362.32K · Q3 2026
- Slotnik Capital, LLC 39.93K sh · $330.62K · Q3 2026
More on Fortress Investment Group LLC
FAQ
How long has Fortress Investment Group LLC held RNA?
Fortress Investment Group LLC has disclosed RNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Fortress Investment Group LLC's current position in RNA?
As of Q3 2026, Fortress Investment Group LLC holds 20.00K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $165.60K, representing 0.03% of its reported portfolio and ranking #24.
Has Fortress Investment Group LLC been buying or selling RNA?
In the latest 13F filing (Q3 2026), Fortress Investment Group LLC newly opened its position in RNA.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, O'Connor Alternative Investments LLC, among 88 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.